|
1
|
Applegate CC and Lane MA: Role of
retinoids in the prevention and treatment of colorectal cancer.
World J Gastrointest Oncol. 7:184–203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fellner C: Promising drugs in clinical
development to treat advanced colorectal cancer. PT. 42:262–265.
2017.
|
|
3
|
Banjerdpongchai R, Chanwikruy Y,
Rattanapanone V and Sripanidkulchai B: Induction of apoptosis in
the human Leukemic U937 cell line by Kaempferia parviflora
Wall.ex.Baker extract and effects of paclitaxel and camptothecin.
Asian Pac J Cancer Prev. 10:1137–1140. 2009.PubMed/NCBI
|
|
4
|
Weaver BA: How Taxol/paclitaxel kills
cancer cells. Mol Biol Cell. 25:2677–2681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Owona BA and Schluesener HJ: Molecular
insight in the multifunctional effects of oridonin. Drugs RD.
15:233–244. 2015. View Article : Google Scholar
|
|
6
|
Liu Y, Liu YZ, Zhang RX, Wang X, Meng ZJ,
Huang J, Wu K, Luo JY, Zuo GW, Chen L, et al: Oridonin inhibits the
proliferation of human osteosarcoma cells by suppressing
Wnt/β-catenin signaling. Int J Oncol. 45:795–803. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu QX, Yuan SX, Ren CM, Yu Y, Sun WJ, He
BC and Wu K: Oridonin upregulates PTEN through activating p38 MAPK
and inhibits proliferation in human colon cancer cells. Oncol Rep.
35:3341–3348. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu J, Chen X, Qu S, Yao B, Xu Y, Wu J, Jin
Y and Ma C: Oridonin induces G2/M cell cycle arrest and apoptosis
via the PI3K/Akt signaling pathway in hormone-independent prostate
cancer cells. Oncol Lett. 13:2838–2846. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bollum LK, Huse K, Oksvold MP, Bai B,
Hilden VI, Forfang L, Yoon SO, Wälchli S, Smeland EB and Myklebust
JH: BMP-7 induces apoptosis in human germinal center B cells and is
influenced by TGF-β receptor type I ALK5. PLoS One.
12:e01771882017. View Article : Google Scholar
|
|
10
|
Yoo HS, Kim GJ, Song DH, Chung KH, Lee KJ,
Kim DH and An JH: Calcium supplement derived from Gallus gallus
domesticus promotes BMP-2/RUNX2/SMAD5 and suppresses TRAP/RANK
expression through MAPK signaling activation. Nutrients.
9:E5042017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bernatik O, Radaszkiewicz T, Behal M, Dave
Z, Witte F, Mahl A, Cernohorsky NH, Krejci P, Stricker S and Bryja
V: A novel role for the BMP antagonist noggin in sensitizing cells
to non-canonical Wnt-5a/Ror2/disheveled pathway activation. Front
Cell Dev Biol. 5:472017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Chen X, Qiao M, Zhang BQ, Wang N,
Zhang Z, Liao Z, Zeng L, Deng Y, Deng F, et al: Bone morphogenetic
protein 2 inhibits the proliferation and growth of human colorectal
cancer cells. Oncol Rep. 32:1013–1020. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Basu S, Haase G and Ben-Ze'ev A: Wnt
signaling in cancer stem cells and colon cancer metastasis. F1000
Res. 5:699–709. 2016. View Article : Google Scholar
|
|
14
|
Ren CM, Li Y, Chen QZ, Zeng YH, Shao Y, Wu
QX, Yuan SX, Yang JQ, Yu Y, Wu K, et al: Oridonin inhibits the
proliferation of human colon cancer cells by upregulating BMP7 to
activate p38 MAPK. Oncol Rep. 35:2691–2698. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Briest F and Grabowski P: The p53 network
as therapeutic target in gastroenteropancreatic neuroendocrine
neoplasms. Cancer Treat Rev. 41:423–430. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu L, Harutyunyan K, Jin W, Wu J, Yang T,
Chen Y, Joeng KS, Bae Y, Tao J, et al: RECQL4 regulates p53
function in vivo during skeletogenesis. J Bone Miner Res.
30:1077–1089. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rajeshkumar NV, Dutta P, Yabuuchi S, de
Wilde RF, Martinez GV, Le A, Kamphorst JJ, Rabinowitz JD, Jain SK,
Hidalgo M, et al: Therapeutic targeting of the warburg effect in
pancreatic cancer relies on an absence of p53 function. Cancer Res.
75:3355–3364. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Inobe T, Nozaki M and Nukina N: Artificial
regulation of p53 function by modulating its assembly. Biochem
Biophys Res Commun. 467:322–327. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gan F, Zhou Y, Hou L, Qian G, Chen X and
Huang K: Ochratoxin A induces nephrotoxicity and immunotoxicity
through different MAPK signaling pathways in PK15 cells and porcine
primary splenocytes. Chemosphere. 182:630–637. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koul HK, Pal M and Koul S: Role of p38 MAP
Kinase Signal Transduction in Solid Tumors. Genes Cancer.
4:342–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim GT, Lee SH, Kim JI and Kim YM:
Quercetin regulates the sestrin 2-AMPK-p38 MAPK signaling pathway
and induces apoptosis by increasing the generation of intracellular
ROS in a p53-independent manner. Int J Mol Med. 33:863–869. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo J, Deng ZL, Luo X, Tang N, Song WX,
Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, et al: A protocol
for rapid generation of recombinant adenoviruses using the AdEasy
system. Nat Protoc. 2:1236–1247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Stayce EB, Barbara HJ, Antonio F, Jessica
G, Eunice DR, Betty LC, Sherry CH, Jimmy YC and John MC: Bone
morphogenetic protein signaling and growth suppression in colon
cancer. Am J Physiol Gastrointest Liver Physiol. 291:G135–G145.
2006. View Article : Google Scholar
|
|
25
|
Carvalho C and Glynne-Jones R: Challenges
behind proving efficacy of adjuvant chemotherapy after preoperative
chemora-diation for rectal cancer. Lancet Oncol. 18:e354–e363.
2017. View Article : Google Scholar
|
|
26
|
Link KH, Coy P, Roitman M, Link C,
Kornmann M and Staib L: Minimum volume discussion in the treatment
of colon and rectal cancer: A review of the current status and
relevance of surgeon and hospital volume regarding result quality
and the impact on health economics. Visc Med. 33:140–147. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li D, Han T, Liao J, Hu X, Xu S, Tian K,
Gu X, Cheng K, Li Z, Hua H, et al: Oridonin, a promising
ent-kaurane diterpenoid lead compound. Int J Mol Sci. 17:E13952016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu J, Wold EA, Ding Y, Shen Q and Zhou J:
Therapeutic potential of oridonin and its analogs: From anticancer
and antiinflammation to neuroprotection. Molecules. 23:E4742018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu J, Ding Y, Chen CH, Zhou Z, Ding C,
Chen H, Zhou J and Chen C: A new oridonin analog suppresses
triple-negative breast cancer cells and tumor growth via the
induction of death receptor 5. Cancer Lett. 380:393–402. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gui Z, Luo F, Yang Y, Shen C, Li S and Xu
J: Oridonin inhibition and miR 200b 3p/ZEB1 axis in human
pancreatic cancer. Int J Oncol. 50:111–120. 2017. View Article : Google Scholar
|
|
31
|
Zhang LD, Liu Z, Liu H, Ran DM, Guo JH,
Jiang B, Wu YL and Gao FH: Oridonin enhances the anticancer
activity of NVP-BEZ235 against neuroblastoma cells in vitro and in
vivo through autophagy. Int J Oncol. 49:657–665. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pi J, Jin H, Jiang J, Yang F, Cai H, Yang
P, Cai J and Chen ZW: Single molecule force spectroscopy for
in-situ probing oridonin inhibited ROS-mediated EGF-EGFR
interactions in living KYSE-150 cells. Pharmacol Res. 119:479–489.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yao Z, Xie F, Li M, Liang Z, Xu W, Yang J,
Liu C, Li H, Zhou H and Qu LH: Oridonin induces autophagy via
inhibition of glucose metabolism in p53-mutated colorectal cancer
cells. Cell Death Dis. 8:e26332017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arvelo F, Sojo F and Cotte C: Biology of
colorectal cancer. Ecancermedicalscience. 9:5202015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lochab AK and Extavour CG: Bone
morphogenetic protein (BMP) signaling in animal reproductive system
development and function. Dev Biol. 427:258–269. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tsuji K, Cox K, Gamer L, Graf D,
Economides A and Rosen V: Conditional deletion of BMP7 from the
limb skeleton does not affect bone formation or fracture repair. J
Orthop Res. 28:384–389. 2010.
|
|
37
|
Wang Z, Fu C, Chen Y, Xu F, Wang Z, Qu Z
and Liu Y: FoxC2 enhances BMP7-mediated anabolism in nucleus
pulposus cells of the intervertebral disc. PLoS One.
11:e01477642016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lim M, Chuong CM and Roy-Burman P: PI3K,
Erk signaling in BMP7-induced epithelial-mesenchymal transition
(EMT) of PC-3 prostate cancer cells in 2- and 3-dimensional
cultures. Horm Cancer. 2:298–309. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rodriguez-Martinez A, Alarmo EL, Saarinen
L, Ketolainen J, Nousiainen K, Hautaniemi S and Kallioniemi A:
Analysis of BMP4 and BMP7 signaling in breast cancer cells unveils
time-dependent transcription patterns and highlights a common
synexpression group of genes. BMC Med Genomics. 4:802011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Buijs JT, Henriquez NV, van Overveld PG,
van der Horst G, ten Dijke P and van der Pluijm G: TGF-beta and
BMP7 interactions in tumour progression and bone metastasis. Clin
Exp Metastasis. 24:609–617. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yan P, Klingbiel D, Saridaki Z, Ceppa P,
Curto M, McKee TA, Roth A, Tejpar S, Delorenzi M, Bosman FT, et al:
Reduced expression of SMAD4 is associated with poor survival in
colon cancer. Clin Cancer Res. 22:3037–3047. 2006. View Article : Google Scholar
|
|
42
|
Zhang B, Halder SK, Kashikar ND, Cho YJ,
Datta A, Gorden DL and Datta PK: Antimetastatic role of Smad4
signaling in colorectal cancer. Gastroenterology. 138:969–980.
e961–963. 2010. View Article : Google Scholar
|
|
43
|
Vousden KH and Lane DP: p53 in health and
disease. Nat Rev Mol Cell Biol. 8:275–283. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nayak D, Kumar A, Chakraborty S, Rasool
RU, Amin H, Katoch A, Gopinath V, Mahajan V, Zilla MK, Rah B, et
al: Inhibition of Twist1-mediated invasion by Chk2 promotes
premature senescence in p53-defective cancer cells. Cell Death
Differ. 24:1275–1287. 2017. View Article : Google Scholar : PubMed/NCBI
|
